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926Objective: To investigate the results of emergency endovascular repair of complicated Stanford type B aortic
dissections within 24 hours of symptom onset.
Methods: A retrospective analysis of the clinical data of 30 patients with complicated Stanford type B aortic
dissections who underwent emergency endovascular repair between June 2007 and October 2008. Endovascular
repairs were performed within 24 hours of symptom onset. Stent-grafts were deployed at the first entry tear
through the femoral artery under fluoroscopic guidance. Follow-up computed tomography scans were performed
at 1, 3, 6, 12, and 18 months after treatment.
Results: The mean patient age was 64 years (range, 43–83 years). There were 3 cases associated with rupture,
6 cases associated with refractory hypertension, 15 cases associated with persistent pain, 2 cases associated
with retrograde dissection, and 4 cases associated with malperfusion. The technical success rate was 100%,
and the incidence of immediate postoperative endoleaks was 13.4%. One patient died of dissection rupture within
30 days. The mean follow-up period was 12  8 months. A small, persistent endoleak (<10%) occurred in 1 pa-
tient, and 1 patient died of acute liver failure 2 months after the operation. No stent dislocation, false lumen
expansion, or paraplegia occurred. The false lumen was completely thrombosed in 6 patients and partially throm-
bosed in 19 patients. The mortality rate was 6.67%.
Conclusions: Our results suggest that emergency endovascular repair of complicated Stanford type B aortic
dissections within 24 hours of symptom onset is associated with good outcomes and can decrease mortality.
(J Thorac Cardiovasc Surg 2011;141:926-31)Although conventional methods of surgical treatment for
aortic dissection (AD) have improved, high perioperative
mortality still exists. Medication, although useful in prevent-
ing extension of the dissection or rupture of the aorta, does
not address the anatomic problem.1,2 Endovascular stent-
graft repair of Stanford type B ADs recently has been shown
to achieve significant reduction of both short- and long-term
mortality.3,4 However, it is still controversial whether
endovascular repair should be performed for type B ADs
during the acute stage (14 days). Reports of the in-
hospital mortality rate associated with the emergency endo-
vascular repair of Stanford type B AD vary.3,4 A report by
Tsai and colleagues5 of data from the International Registry
of Acute Aortic Dissection indicated an overall in-hospital
mortality rate of 13%, with most deaths occurring within
the first week. In patients with indications for surgery, the
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Between June 2007 and October 2008, 30 patients with
complicated Stanford type B ADs underwent emergency en-
dovascular repair within 24 hours of symptom onset at the
TongJi Hospital. We report the clinical outcomes of these
patients.
MATERIALS AND METHODS
Subjects
Between June 2007 and October 2008, 46 Stanford type B ADs were
treated in the Department of Vascular Surgery, TongJi Hospital, Shanghai,
China. Of these 46 cases, 16 were uncomplicated and treated conserva-
tively. The other 30 cases (23 male patients, 7 female patients) with compli-
cated Stanford type B ADs, including rupture of the false lumen, continuous
chest pain, refractory hypertension, and visceral or limb ischemia, were
managed with emergency endovascular repair within 24 hours of symptom
onset and included in this analysis. Patient data are presented in Table 1. The
mean age of the patients was 64 years (range 43–83 years), and initial symp-
toms in all patients included severe chest pain and profuse sweating. Of the
30 complicated acute type B dissections, 3 were associated with rupture,
6 were associated with refractory hypertension, 15 were associated with
persistent pain, 2 were associated with retrograde dissection, and 4 were
associated with malperfusion syndrome. Diagnosis was based on contrast-
enhanced computed tomography (CT) in all patients. The study was
approved by the institutional review board of TongJi Hospital, and all
patients provided informed consent.
Aortic Angiography Before Endovascular Repair
In 24 of the 30 cases, the distance from the first entry tear to the inferior
margin of the left subclavian artery (LSA) was 15 mm or more. Amongery c April 2011
Abbreviations and Acronyms
AD ¼ aortic dissection
CT ¼ computed tomography
LSA ¼ left subclavian artery
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the level of diaphragm in 5 cases, and at the level of celiac trunk in 1 case. In
6 of the 30 cases, the distance from the first entry tear to the inferior margin
of the LSA opening was less than 15 mm, and in the case in which the tear
was closest to the LSA, it was almost adjacent to the LSA opening. There
was a second entry tear in 19 cases, and all of the tears were located near
the visceral arteries. There were no cases in which there were more than
2 entry tears. The celiac artery was poorly visualized in 6 cases, and the
superior mesenteric artery was poorly visualized in 2 cases, but there
were no instances in which both arteries were not visualized. At least 1 of
the renal arteries was poorly visualized in 16 cases, and in 3 cases 1 renal
artery was not visualized at all. There were no instances in which both renal
arteries were not visualized. The bilateral iliacofemoral arteries were visu-
alized in all 30 cases.
Endovascular Repair Procedure
General anesthesia was used in all 30 cases, and temporary pacemakers
were implanted as routine in 9 patients with coronary heart diseases. The
first entry tear in the dissection was then repaired by endovascular stent-
graft placement.
Routine endovascular repair was performed in 23 of the 24 cases in
which the distance from the first entry tear to the inferior margin of the
LSA opening was 15 mm or more. The stent graft was applied to close
the entry tear, and the LSA was preserved as previously described.6 An
‘‘open-window’’ stent-grafting technique was used for the endovascular re-
pair in the 1 case in which the first entry tear was near the visceral artery.
In the 6 cases in which the distance from the first entry tear to the inferior
margin of the LSA opening was less than 15 mm, bilateral angiography of
the carotid and vertebral arteries was performed to evaluate the blood supply
to the brain. If the right vertebral artery and basilar artery were normal and
the circle ofWillis was complete (5 cases), a 1-stage repair was performed to
overlap the LSA. In the other case, vascular bypass of the LSA was per-
formed in advance, and then endovascular repair of the AD was performed.
Proximal balloon dilation was performed if a proximal endoleak was
seen on angiography after stent-graft placement. Angiography was then re-
peated 15 minutes after dilation. If the endoleak did not decrease or disap-
pear, our protocol called for an elongated vascular stent to be applied to the
proximal portion.
Patients were monitored for the first 24 hours postoperatively in the in-
tensive care unit, and prophylactic antibiotics, sedatives, and medications to
control blood pressure were administered as necessary. Medtronic Talent
stent grafts (Medtronic Inc, Minneapolis, MN) and minimally invasive stent
grafts made in Shanghai were used in the present study.
Follow-up
Enhanced CT scans, ranging from the aortic arch to the iliacofemoral
arteries, were performed on each patient at 1, 3, 6, 12, and 18 months after
treatment. The stent location, occurrence of endoleaks, and blood supply of
the internal organs and false lumens were recorded.
Data Analysis
Surgical outcomes, complications occurring within 30 days after the op-
eration, and death of the patient during the 18-month postoperative follow-
up period were considered as end points. The survival status of the patient,The Journal of Thoracic and Calocation and morphology of the graft, presence of endoleaks, blood supply
to the visceral arteries, and false lumen thrombosis were evaluated.
RESULTS
Surgical Results
Representative images of routine endovascular repair,
1-stage stent-graft repair to overlap the LSA, and ‘‘open-
window’’ stent grafting are presented in Figures 1, 2, and
3, respectively.
The stent graft was successfully placed in the first entry
tear in all 30 cases, and there was no stent displacement, aor-
tic rupture, necessity for open chest surgery, or occurrence of
postoperative paraplegia in any patient. In the patient in
whom the first entry tear was located at the opposite side
of the celiac trunk in the descending aorta, the stent success-
fully closed the tear in the intima and the celiac trunk and
superior mesenteric artery were well visualized on the
postoperative angiogram and on contrast-enhanced CT per-
formed 1 week postoperatively.
Aortic angiography immediately after endovascular repair
revealed endoleaks in 4 cases (13.3%). Proximal balloon di-
lation was performed, and the endoleak resolved in 3 cases.
In the other case, the rate of the endoleak was less than 10%;
thus, no further treatment was performed. The blood supply
of the true lumen improved in all patients. The mean opera-
tion time was 1.5 hours (range, 0.5–5.0 hours), the mean
blood loss was 170 mL (range, 60–400 mL), and the mean
hospitalization time was 14 days (range, 10–21 days).
Complications Within 30 Days After Endovascular
Repair
One patient inwhom the distance from the superiormargin
of the first entry tear to the inferior margin of the LSA open-
ing was less than 15 mm and one third of the LSA was over-
lapped by the stent graft died of rupture of the dissection. The
patient experienced sudden onset of chest pain, dyspnea, and
hypotension 48 hours after the operation (Table 2). Autopsy
indicated that death was caused by rupture of a retrograde
tear of the dissection and subsequent rupture of the ascending
aorta. The possible reason for the occurrence is that the LSA
and the entry tear were not completely covered by the stent
because the entry tear was located close to the LSA opening.
New-onset renal dysfunction occurred in 1 patient 12 hours
after the operation and was thought to be caused by hypoten-
sion during the procedure and subsequent ischemia–reperfu-
sion injury (Table 2). The patient’s renal function recovered
with conservative treatment. In 1 case, contrast-enhanced CT
scan performed 1 week after the procedure revealed an endo-
leak of less than 10% (Table 2). No enlargement of the false
lumen was seen, and the blood supply to the internal organs
was sufficient; thus, no treatment was administered. A post-
operative wound infection caused by lymphatic leakage oc-
curred in 1 case (Table 2), which resolved with conservative
treatment in 2 weeks.rdiovascular Surgery c Volume 141, Number 4 927
TABLE 1. Demographic data of 30 patients with complicated Stanford
type B aortic dissections
Item No.
Gender (M/F) 23/7
Age (y) 64  19
Smoking 20 (66.7)
Hypertension 24 (80.0)
Diabetes 7 (23.3)
Coronary heart disease 9 (30.0)
Renal failure 1 (3.3)
Chronic obstructive pulmonary disease 4 (13.3)
Data are presented as mean  standard deviation or number (percentage).
TABLE 3. Results of postoperative follow-up
Follow-up duration (mo) 12  8
Death 1 (3.3)
Endoleak 1 (3.3)
Chronic renal dysfunction 1 (3.3)
Paraplegia 0 (0)
Stent displacement 0 (0)
Complete thrombosis 6 (20.0)
Partial thrombosis 19 (64.6)
Data are presented as mean  standard deviation or number (percentage).
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The mean follow-up period was 12  8 months (range,
1–19 months). Two cases were lost to follow-up after
1 month, and thrombosis of false lumen was not observed
when last seen. One patient died of acute liver failure
2 months after the operation, and arterial thromboembolism
was considered the probably cause (Table 3). The small en-
doleak found in 1 patient postoperatively was still present in
the 12-month follow-up; however, no enlargement of the
dissection and no new endoleaks were observed.
At last follow-up, there were no stent dislocations, expan-
sion of the false lumens, or paraplegia noted. The false
lumen was completely thrombosed in 6 patients and partially
thrombosed in 19 patients (Table 3). The total mortality rate
was 6.67%.DISCUSSION
Mortality in patients with Stanford type B ADs is 30%
during the acute stage (<14 days after onset), and the
5-year survival is only 10%.7,8 At present, endovascular
stent-graft repair of Stanford type B ADs can be performed
in most cases, and it is also used for certain complicated
cases that are difficult to manage with conventional
surgery.9
The 1-year mortality and incidence of complications with
endovascular stent-graft repair are significantly lower than
those of conventional open surgery, and the thrombosis
rate of the false lumen is significantly higher.10,11
Although the safety and efficacy of endovascular repair of
AD have been reported by many studies,11,12 it is still
controversial whether endovascular repair can be
performed during the acute stage of ADs. Most scholarsTABLE 2. Complications occurring within 30 days postoperatively
Complication Cases (rate)
Death 1 (3.3)
Endoleak 4 (13.3)
Post-implantation syndrome 6 (20.0)
New onset renal failure 1 (3.3)
Wound infection 1 (3.3)
Data are presented as number (percentage).
928 The Journal of Thoracic and Cardiovascular Surgbelieve that stent-graft repair should not be used during
the early stage of Stanford type B ADs because congestion
and edema of the artery wall prevent effective support of
the stent. However, along with continued improvement in
instruments and techniques, it has been recently reported
that emergency endovascular treatment of Stanford type B
ADs can be carried out safely and effectively.13,14
The acute stage of an AD is considered to last up to 14
days. There have been no reports comparing the outcomes
of endovascular treatments performed during different pe-
riods of the acute stage. Chen and colleagues15 suggested
that the first 24 hours after symptom onset should be defined
as the early period of the acute stage, and the duration
between 24 hours and 2 weeks should be defined as the
late period of the acute stage. The mortality within the first
24 hours of symptom onset in patients with Stanford type
B ADs is reported to be as high as 25%8; therefore, we per-
formed emergency endovascular stent-graft repair within
this time period.
One of the 30 patients in this study died within 30 days of
the procedure, and the possible reason was that the LSA and
entry tear were not completely covered by the stent because
the entry tear was located close to the LSA opening. One pa-
tient died of acute liver failure 2 months after the operation,
and arterial thromboembolism was considered the possible
cause. Thus, the total mortality rate was 6.67%.
Verhoye and colleagues16 performed endovascular repair
of Stanford type B ADs within 48 hours of symptom onset.
The authors reported an early mortality of 25% and no de-
layed deaths related to the treatment. Feezor and colleagues17
performed endovascular repair of Stanford type B ADs 2.9
4.1 days after symptom onset and reported a mortality rate of
21% during the first 30 hospital days. Endovascular repair of
Stanford type B ADs performed during the late period of the
acute stage has been associatedwith 30-daymortality ranging
from 2.6% to 10.7%.3,18,19 The present study suggests that
endovascular repair of Stanford type B ADs within 24
hours of symptom onset is associated with a lower 30-day
mortality compared with endovascular repair performed
during later periods of the acute stage. This difference may
be related to varying stages of aortic wall swelling,
inflammation, and vascular reconstruction seen during
different periods of the acute stage.ery c April 2011
FIGURE 1. Routine endovascular stent-graft treatment was performed for patients with the first entry tear 15mmormore from the inferior margin of the LSA
opening. The stent-graft was placed close to the proximal end of the LSA to enhance the supportive strength of the anchoring area.
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hours after symptom onset. During the first 24 hours, the
false lumen is not significantly expanded, remodeling of
the vessel has not occurred, and compliance is still good.
Therefore, if endovascular repair is performed in this period,
the blood supply of the true lumen can easily recover,
remodeling of the false lumen can occur, and the aorta can
recover completely. Sayer and colleagues20 reported signif-
icant remodeling of the aorta after emergency endovascular
repair of type B dissections, and no such change was found
during the chronic stage.
The timing of treatment is critical in patients with an ob-
structed blood supply, and early stent-graft implantation can
reduce ischemia of internal organs and limbs, with minimal
ischemia being one of the key elements of successful treat-
ment. In the present study, postoperative angiography indi-
cated the blood supply of the visceral arteries improved
significantly after surgery in all 30 cases; the emergency op-
eration reduced ischemia time and the possibility of ische-
mia–reperfusion injury.FIGURE 2. For patients with the first entry tear less than 15 mm from the inferi
tebral arteries was performed to evaluate the blood supply to the brain. If the ri
complete, then a 1-stage repair was performed to overlap the LSA to enhance th
The Journal of Thoracic and CaBecause of the arterial wall swelling and brittleness that
occur during the acute stage, endoleaks were treated with
caution. The diameter of the stent used was 115% of the aor-
tic diameter in the anchoring area. If the diameter of the stent
is too large, the aorta will be excessively expanded, and such
expansion may aggravate swelling and possibly lead to rup-
ture. If the diameter is too small, complications such as en-
doleaks and stent displacement may occur when swelling
of the aortic wall decreases during the remodeling stage. Be-
cause maximum inflammation and swelling are not reached
until 24 hours after symptom onset, we did not use stents
with diameters that were 115% or greater than that of the
aorta in the anchoring area. Endoleaks were found in 4 cases
(13.3%) immediately after endovascular repair. Proximal
balloon dilation was then performed, and the endoleaks
resolved in 3 cases and became minimal in 1 case, and the
visceral blood supply improved in all patients.
Guo and colleagues21 believe that endoleaks after endo-
vascular repair are not related to the type and stage of the
lesion, but to the anatomic location of the entry tear. Anor margin of the LSA opening, bilateral angiography of the carotid and ver-
ght vertebral and basilar arteries were normal, and the circle of Willis was
e length and supportive strength of the anchoring area.
rdiovascular Surgery c Volume 141, Number 4 929
FIGURE 3. A, Preoperative contrast-enhanced CT suggested that the first entry tear was located at the opposite side of the celiac trunk in the descending
aorta. B, An ‘‘open-window’’ stent-grafting was applied for the endovascular repair, and immediate postoperative angiography indicated that there was no
false lumen, and the celiac trunk and the superior mesenteric artery were well visualized. C, Follow-up contrast-enhanced CT showed that the location of the
stent was excellent, complete thrombosis of the false lumen had occurred, and the visceral artery was clearly visualized.
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important predictor of endoleak occurrence, and therefore
the length and strength of the proximal interface of the stent
should be enhanced to effectively reduce the chance of an
endoleak. Thus, we performed a 1-stage repair to overlap
the LSA in 5 cases and a left common carotid artery-to-930 The Journal of Thoracic and Cardiovascular SurgLSA vascular bypass surgery in 1 case to reduce the possi-
bility of an endoleak. Despite our attempts, angiography re-
vealed endoleaks in 4 cases. This may have been related to
insufficient expansion of the stent graft after implantation
or perhaps to intraoperative anticoagulation. It is reported
that small endoleaks will close after 3 to 6 months withoutery c April 2011
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Dany treatment.22 However, because our patients were treated
within 24 hours of symptom onset, the possibility of an en-
doleak progressing was high because of aortic wall inflam-
mation and swelling endoleak progressing was high;
therefore, we routinely performed balloon dilation to reduce
the endoleak.
A second entry tear was present in 19 of the 30 cases, and
no treatment was performed for these tears. In theory, after
repair of the first entry tear, blood flow into the false lumen
stops, pressure in the false lumen decreases, pressure in the
true lumen increases, and thrombosis occurs gradually from
top to bottom inside the false lumen. However, the existence
of second and third-entry tears in ADs will significantly af-
fect thrombosis of the false lumen,23 and further studies of
the best management of multiple tears are needed. The rate
of partial and complete false lumen thrombosis was
84.6% in our study, a rate significantly lower than the
95.7% rate reported by the Chen and colleagues.15 This dif-
ference may be related to the different follow-up durations
and case numbers in the 2 studies.
CONCLUSIONS
Endovascular repair of AD is a minimally invasive and
safe technique with reliable short-term efficacy that greatly
improves the quality of life of patients. Our results suggest
that emergency endovascular repair of Stanford type B
ADs within 24 hours of symptom onset can significantly de-
crease the mortality of patients in the acute stage. Further
studies are required for evaluation of these findings.
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